These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31269846)

  • 1. Mineral and bone disorder in hemodialysis patients in the Tibetan Plateau: a multicenter cross-sectional study.
    Dang ZH; Tang C; Li GL; Luobu C; Qing D; Ma ZH; Qu JF; Suolang L; Liu LJ
    Ren Fail; 2019 Nov; 41(1):636-643. PubMed ID: 31269846
    [No Abstract]   [Full Text] [Related]  

  • 2. Mineral and bone disorder in Chinese dialysis patients: a multicenter study.
    Kong X; Zhang L; Zhang L; Chen N; Gu Y; Yu X; Liu W; Chen J; Peng L; Yuan W; Wu H; Chen W; Fan M; He L; Ding F; Chen X; Xiong Z; Zhang J; Jia Q; Shi W; Xing C; Tang X; Hou F; Shu G; Mei C; Wang L; Xu D; Ni Z; Zuo L; Wang M; Wang H
    BMC Nephrol; 2012 Sep; 13():116. PubMed ID: 22994525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Epidemiology of Mineral Bone Disorder Markers in Prevalent Hemodialysis Patients in the Xinjiang Uyghur Autonomous Region in China.
    Sun YP; Yang WJ; Li SH; Han YY; Liu J
    Biomed Res Int; 2017; 2017():2516934. PubMed ID: 28299319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China.
    Tao S; Li X; Liu Z; Bai Y; Qian G; Wu H; Li J; Guo Y; Yang S; Chen L; Yang J; Han J; Ma S; Yang J; Yu L; Shui R; Jin X; Wang H; Zhang F; Chen T; Li X; Zong X; Liu L; Fan J; Wang W; Zhang Y; Shi G; Wang D
    Int Urol Nephrol; 2023 Feb; 55(2):389-398. PubMed ID: 35951256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Hemodialysis Patient Outcomes and Compliance with KDOQI and KDIGO Targets for Mineral and Bone Metabolism.
    Djukanović L; Dimković N; Marinković J; Djurić Ž; Knežević V; Lazarević T; Ljubenović S; Marković R; Rabrenović V
    Nephron; 2016; 132(3):168-74. PubMed ID: 26914677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.
    Soohoo M; Feng M; Obi Y; Streja E; Rhee CM; Lau WL; Wang J; Ravel VA; Brunelli S; Kovesdy CP; Kalantar-Zadeh K
    Am J Nephrol; 2016; 43(2):85-96. PubMed ID: 26950688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hemodialysis patients without marked elevation of intact parathyroid hormone are also good candidates for early intervention with cinacalcet.
    Nishida H; Masakane I; Kudo K; Ito M; Tanida H; Koshika M; Nishida W; Tomita Y
    Ther Apher Dial; 2013 Jun; 17(3):325-31. PubMed ID: 23735149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CKD-MBD Markers with All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in Beijing.
    Li D; Zhang L; Zuo L; Jin CG; Li WG; Chen JB
    PLoS One; 2017; 12(1):e0168537. PubMed ID: 28045985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: Initial findings from the dialysis outcomes and practice patterns study (2012-2015).
    Al Salmi I; AlRukhaimi M; AlSahow A; Shaheen FA; Al-Ghamdi SM; AlAli F; AlGhareeb S; Al Maimani Y; AlGhonaim M; Bieber B; Tentori F; Pisoni RL;
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):62-80. PubMed ID: 27991480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D levels and other biochemical parameters of mineral bone disorders and their association with diastolic dysfunction and left ventricular mass in young nondiabetic adult patients with chronic kidney disease.
    Sonkar SK; Bhutani M; Sonkar GK; Pandey SK; Chandra S; Bhosale V
    Saudi J Kidney Dis Transpl; 2017; 28(4):758-763. PubMed ID: 28748877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and pattern of chronic kidney disease-mineral bone disorders among hemodialysis patients in kano, northwest nigeria.
    Abdu A; Abdu A; Arogundade FA
    Ann Afr Med; 2019; 18(4):191-195. PubMed ID: 31823953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypes of Mineral Bone Disorder in Chronic Kidney Disease in a Dialysis Population.
    Rojas-Campos E; Ruvalcaba-Contreras N; Campos-Mariz A; Aguilar-Campos A; Andrade-Sierra J; Cerrillos-Gutiérrez JI; Medina-Pérez M; Evangelista-Carrillo L; Banda A; Cueto-Manzano AM
    Arch Med Res; 2024 Jun; 55(4):103008. PubMed ID: 38824883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of parathyroid hormone concentration in hemodialysis patients.
    Li J; Molnar MZ; Zaritsky JJ; Sim JJ; Streja E; Kovesdy CP; Salusky I; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Jun; 28(6):1516-25. PubMed ID: 23348879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D study.
    Fukagawa M; Fukuma S; Onishi Y; Yamaguchi T; Hasegawa T; Akizawa T; Kurokawa K; Fukuhara S
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1473-80. PubMed ID: 22822017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
    Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D
    Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of biochemical disturbances of chronic kidney disease - mineral and bone disorders (CKD-MBD) in a nation-wide peritoneal dialysis cohort: are guideline goals too hard to achieve?
    Weissheimer R; Bucharles SGE; Truyts CAM; Jorgetti V; Figueiredo AE; Barrett P; Olandoski M; Pecoits-Filho R; Moraes TP
    J Bras Nefrol; 2021; 43(2):173-181. PubMed ID: 33538758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.
    Wang M; Obi Y; Streja E; Rhee CM; Lau WL; Chen J; Hao C; Hamano T; Kovesdy CP; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1118-1127. PubMed ID: 28487345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relation Between Variability of Intact Parathyroid Hormone, Calcium, and Cardiac Mortality in Hemodialysis Patients.
    Ulusoy S; Ozkan G; Guvercin B; Yavuz A
    Artif Organs; 2016 Nov; 40(11):1078-1085. PubMed ID: 27110947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current status of chronic kidney disease-mineral and bone disorder management in China.
    Zhan Y; He X; Hong D; Wang L; Li G
    Sci Rep; 2022 Oct; 12(1):16694. PubMed ID: 36202866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.